KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Gross Margin (2016 - 2026)

Quest Diagnostics' Gross Margin history spans 18 years, with the latest figure at 32.54% for Q1 2026.

  • On a quarterly basis, Gross Margin changed 0.0% to 32.54% in Q1 2026 year-over-year; TTM through Mar 2026 was 33.2%, a 36.0% increase, with the full-year FY2025 number at 33.21%, up 35.0% from a year prior.
  • Gross Margin hit 32.54% in Q1 2026 for Quest Diagnostics, roughly flat from 32.43% in the prior quarter.
  • Over the last five years, Gross Margin for DGX hit a ceiling of 36.96% in Q1 2022 and a floor of 32.17% in Q4 2023.
  • Historically, Gross Margin has averaged 33.38% across 5 years, with a median of 32.85% in 2023.
  • Biggest five-year swings in Gross Margin: tumbled -490bps in 2022 and later surged 110bps in 2025.
  • Tracing DGX's Gross Margin over 5 years: stood at 32.49% in 2022, then decreased by -1bps to 32.17% in 2023, then rose by 2bps to 32.74% in 2024, then fell by -1bps to 32.43% in 2025, then increased by 0bps to 32.54% in 2026.
  • Business Quant data shows Gross Margin for DGX at 32.54% in Q1 2026, 32.43% in Q4 2025, and 33.7% in Q3 2025.